Literature DB >> 9352357

The role of I-Ag7 beta chain in peptide binding and antigen recognition by T cells.

O Kanagawa1, J Shimizu, E R Unanue.   

Abstract

We examine here how the beta chain of the class II MHC molecule I-Ag7 influences T cell recognition. Three sets of T cell clones were identified. The first set recognizes peptides bound to I-Ag7, I-Ad and I-Ag7 mutant in which the allele-specific residues His and Ser at position 56 and 57 were changed to the Pro at residue 56 and to non-polymorphic Asp at residue 57. The second set responds to the antigen presented only by I-Ag7 and does not recognize the peptides bound to the other class II molecules. The third set is also specific for I-Ag7 as a result of the poor binding of the peptide to I-Ad and the mutant I-Ag7. These results indicate that positions 56 and 57 of the I-Ag7 class II MHC beta chain play a role in both T cell recognition of the MHC-peptide complex and peptide binding to MHC. These two different functions may be involved in I-Ag7-restricted beta cell antigen recognition by diabetogenic T cell clones.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352357     DOI: 10.1093/intimm/9.10.1523

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  3 in total

1.  Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.

Authors:  Li Zhang; Frances Crawford; Liping Yu; Aaron Michels; Maki Nakayama; Howard W Davidson; John W Kappler; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

2.  In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes.

Authors:  L Wen; F S Wong; J Tang; N Y Chen; M Altieri; C David; R Flavell; R Sherwin
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

3.  Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes.

Authors:  Janet M Wenzlau; James E DiLisio; Gene Barbour; Mylinh Dang; Anita C Hohenstein; Maki Nakayama; Thomas Delong; Rocky L Baker; Kathryn Haskins
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.